ICCM vs. CVRX, NNOX, OM, INGN, NYXH, TLSI, CV, ELMD, KRMD, and INFU
Should you be buying IceCure Medical stock or one of its competitors? The main competitors of IceCure Medical include CVRx (CVRX), Nano-X Imaging (NNOX), Outset Medical (OM), Inogen (INGN), Nyxoah (NYXH), TriSalus Life Sciences (TLSI), CapsoVision (CV), Electromed (ELMD), KORU Medical Systems (KRMD), and InfuSystem (INFU). These companies are all part of the "medical equipment" industry.
IceCure Medical vs. Its Competitors
IceCure Medical (NASDAQ:ICCM) and CVRx (NASDAQ:CVRX) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their media sentiment, profitability, earnings, valuation, institutional ownership, analyst recommendations, dividends and risk.
0.6% of IceCure Medical shares are owned by institutional investors. Comparatively, 75.3% of CVRx shares are owned by institutional investors. 2.4% of IceCure Medical shares are owned by company insiders. Comparatively, 13.9% of CVRx shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.
IceCure Medical currently has a consensus target price of $2.64, suggesting a potential upside of 223.19%. CVRx has a consensus target price of $14.00, suggesting a potential upside of 40.70%. Given IceCure Medical's higher probable upside, analysts clearly believe IceCure Medical is more favorable than CVRx.
IceCure Medical has higher earnings, but lower revenue than CVRx. IceCure Medical is trading at a lower price-to-earnings ratio than CVRx, indicating that it is currently the more affordable of the two stocks.
CVRx has a net margin of -95.61% compared to IceCure Medical's net margin of -317.62%. CVRx's return on equity of -79.31% beat IceCure Medical's return on equity.
In the previous week, IceCure Medical had 2 more articles in the media than CVRx. MarketBeat recorded 2 mentions for IceCure Medical and 0 mentions for CVRx. IceCure Medical's average media sentiment score of 0.45 beat CVRx's score of 0.00 indicating that IceCure Medical is being referred to more favorably in the media.
IceCure Medical has a beta of 0.31, meaning that its share price is 69% less volatile than the S&P 500. Comparatively, CVRx has a beta of 1.26, meaning that its share price is 26% more volatile than the S&P 500.
Summary
CVRx beats IceCure Medical on 10 of the 16 factors compared between the two stocks.
Get IceCure Medical News Delivered to You Automatically
Sign up to receive the latest news and ratings for ICCM and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding ICCM and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
IceCure Medical Competitors List
Related Companies and Tools
This page (NASDAQ:ICCM) was last updated on 10/17/2025 by MarketBeat.com Staff
